Trial intelligence / Profile preview

Phase IV Open-label Safety Study of H5N1 Pre-pandemic Vaccine BK-KIB-01 in Japanese Quarantine and Related Workers

jRCT1090220019Phase 4Completed

Sponsor
National Hospital Organization Mie National Hospital
Start
Jul 2008
Countries
1
01

Overview

Phase 4, open-label trial in influenza (2 arms), sponsored by National Hospital Organization Mie National Hospital. Primary endpoint: Safety endpoints. Started Jul 2008; status: completed.

02

Conditions

influenza

Beyond the preview

Go deeper on jRCT1090220019.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1090220019.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call